GTHX Jul 2024 3.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3000

0.0000

(0.00%)

As of 02:24PM EDT. Market open.

Loading interactive chart…

Simply Wall St.
It's Probably Less Likely That G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Will See A Huge Pay Rise This Year
Key Insights G1 Therapeutics will host its Annual General Meeting on 13th of June Total pay for CEO Jack Bailey...
GlobeNewswire
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 4,650 shares of G1’s common stock and 2,400 restricted stock units (RSUs) to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”). These equity awards were granted as an inducement material to th
Simply Wall St.
G1 Therapeutics (NASDAQ:GTHX shareholders incur further losses as stock declines 19% this week, taking three-year losses to 84%
Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So consider, for a...